Similar articles

• Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.

  Leather HL, Correll TA, Meyer CL, Schmalfuss IM, Wingard JR. Leather HL, et al. Clin Adv Hematol Oncol. 2005 Oct;3(10):773-7. Clin Adv Hematol Oncol. 2005. PMID: 16258487 No abstract available.
• Cutaneous zygomycosis due to Rhizopus oryzae in a patient with acute lymphoblastic leukemia.

  Sundararajan T, Kumar CP, Menon T, Rekha K, Venkatadesikalu M. Sundararajan T, et al. Mycoses. 2004 Dec;47(11-12):521-3. doi: 10.1111/j.1439-0507.2004.01051.x. Mycoses. 2004. PMID: 15601461
• Posaconazole mono- or combination therapy for treatment of murine zygomycosis.

  Ibrahim AS, Gebremariam T, Schwartz JA, Edwards JE Jr, Spellberg B. Ibrahim AS, et al. Antimicrob Agents Chemother. 2009 Feb;53(2):772-5. doi: 10.1128/AAC.01124-08. Epub 2008 Oct 20. Antimicrob Agents Chemother. 2009. PMID: 18936190 Free PMC article.
• Current experience in treating invasive zygomycosis with posaconazole.

  Cornely OA, Vehreschild JJ, Rüping MJ. Cornely OA, et al. Clin Microbiol Infect. 2009 Oct;15 Suppl 5:77-81. doi: 10.1111/j.1469-0691.2009.02985.x. Clin Microbiol Infect. 2009. PMID: 19754763 Review.
• Acute cutaneous zygomycosis of the scalp: A case report and literature review.

  Alseady A, Baharoon S. Alseady A, et al. J Infect Public Health. 2015 Jul-Aug;8(4):377-81. doi: 10.1016/j.jiph.2014.12.005. Epub 2015 Apr 3. J Infect Public Health. 2015. PMID: 25843449 Review.